Authors: Violette, SM Guan, W Bartlett, C Smith, JA Bardelay, C Antoine, E Rickles, RJ Mandine, E Van Schravendijk, MR Adams, SE Lynch, BA Shakespeare, WC Yang, M Jacobsen, VA Takeuchi, CS Macek, KJ Bohacek, RS Dalgarno, DC Weigele, M Lesuisse, D Sawyer, TK Baron, R

Citation: Sm. Violette et al., Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption, BONE, 28(1), 2001, pp. 54-64

Authors: Bohacek, RS Dalgarno, DC Hatada, M Jacobsen, VA Lynch, BA Macek, KJ Merry, T Metcalf, CA Narula, SS Sawyer, TK Shakespeare, WC Violette, SM Weigele, M

Citation: Rs. Bohacek et al., X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor, J MED CHEM, 44(5), 2001, pp. 660-663

Authors: Shakespeare, WC Bohacek, RS Azimioara, MD Macek, KJ Luke, GP Dalgarno, DC Hatada, MH Lu, XD Violette, SM Bartlett, C Sawyer, TK

Citation: Wc. Shakespeare et al., Structure-based design of novel bicyclic nonpeptide inhibitors for the SrcSH2 domain, J MED CHEM, 43(21), 2000, pp. 3815-3819